GSTM1 and anemia (phenotype): More recently, the NICE guidelines (National Institute for Health and Care Excellence [NICE], 2015), and the Renal Association clinical practice guidelines on anemia of CKD (Mikhail et al., 2017), both suggested a Hb target range of 10–12 g/dL.